✦ LIBER ✦

Chronic non-A, non-B hepatitis complicated by end-stage renal failure treated with recombinant interferon alpha

✍ Scribed by Michael Edward Ellis; Osman Alfurayh; Magid Abdelhalim Halim; Jens Otto Sieck; Mohamed Ashraf Ali; Stener Stenbjerg Bernvil; Hatim Ali; Yousri Barn; Asif Ayub; Mohammed Al-Fadda

Book ID: 118566225
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 543 KB
Volume: 18
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(05)80248-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Histological outcome in interferon alpha

Histological outcome in interferon alpha-2b treated patients with chronic posttransfusion non-A, non-B hepatitis

✍ Robert Schvarcz; Hans Glaumann; Ola Weiland; Gunnar Norkrans; Rune Wejstål; Aril 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 916 KB

Detection of interferon-alpha expression

Detection of interferon-alpha expression by PCR in patients with chronic hepatitis C and hepatitis non-A, non-B

✍ EVELYN R. BRANDT; RODNEY J. DEVENISH; PAUL J. HERTZOG; FRANCIS J. DUDLEY; ANTHON 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 971 KB

Tenoxicam, a non-steroid anti-inflammato

Tenoxicam, a non-steroid anti-inflammatory drug, is unable to increase the response rate in patients with chronic hepatitis C treated by alpha interferon

✍ Jean-Pierre Zarski; Marianne Maynard-Muet; Suzanne Chousterman; Maryline Baud; R 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

The purpose of this study is to compare a combination of interferon (IFN)-␣ 2 a (Roferon) ؉ Tenoxicam with IFN-␣ 2 a alone in the treatment of chronic hepatitis C. This prospective, randomized double-blind study included 149 patients, all of whom were diagnosed with active chronic hepatitis C but no